CARGO Therapeutics (CRGX)

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

CRGX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
14 Nov 23	Perceptive Advisors	Common Stock	Buy	Acquire P	Yes	No	15	333,333	5.00 mm	333,333
14 Nov 23	Perceptive Advisors	Common Stock	Buy	Acquire P	Yes	No	15	333,333	5.00 mm	2,912,835
14 Nov 23	Perceptive Advisors	Common Stock	Conversion	Acquire C	Yes	No	0	2,579,502	0.00	2,579,502
14 Nov 23	Perceptive Advisors	Series A-1 Convertible Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	2,579,502	0.00	0
14 Nov 23	Third Rock Ventures V	Common Stock	Buy	Acquire P	Yes	No	15	1,333,333	20.00 mm	1,807,119
14 Nov 23	Third Rock Ventures V	Common Stock	Conversion	Acquire C	Yes	No	0	473,786	0.00	473,786
14 Nov 23	Third Rock Ventures V	Common Stock	Conversion	Acquire C	No	No	0	1,737,216	0.00	1,737,216
14 Nov 23	Third Rock Ventures V	Series A-1 Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	6,428,571	0.00	0
14 Nov 23	Third Rock Ventures V	Series A-1 Preferred Stock Common Stock	Conversion	Dispose C	No	No	0	23,571,429	0.00	0
14 Nov 23	Wellington Biomedical Innovation Master Investors	Common Stock	Conversion	Acquire C	No	No	0	737,000	0.00	737,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Truist Securities Initiates Coverage On Cargo Therapeutics with Buy Rating, Announces Price Target of $34

5 Dec 23

Truist Securities analyst Asthika Goonewardene initiates coverage on Cargo Therapeutics (NASDAQ:CRGX) with a Buy rating and announces Price Target of $34.

TD Cowen Initiates Coverage On Cargo Therapeutics with Outperform Rating

5 Dec 23

TD Cowen analyst Tyler Van Buren initiates coverage on Cargo Therapeutics (NASDAQ:CRGX) with a Outperform rating.

JP Morgan Initiates Coverage On Cargo Therapeutics with Overweight Rating, Announces Price Target of $23

5 Dec 23

JP Morgan analyst Brian Cheng initiates coverage on Cargo Therapeutics (NASDAQ:CRGX) with a Overweight rating and announces Price Target of $23.

Jefferies Initiates Coverage On Cargo Therapeutics with Buy Rating, Announces Price Target of $28

5 Dec 23

Insiders Buying C.H. Robinson Worldwide And 3 Other Stocks

17 Nov 23